Mount Sinai Hospital neurologist Bernard Sachs, MD, published the first description in United States of amaurotic familial idiocy, later known as Tay-Sachs disease.

Mount Sinai opened the Neurology Clinic in the dispensary on 67th Street.

Bernard Sachs, MD, became editor of the Journal of Nervous and Mental Diseases and is named President of the American Neurological Association.

Established the in-patient neurological service, the first in a New York hospital.

Mount Sinai dedicated our first neurological ward.

Neurologist Israel Strauss, MD, Founder of the Journal of the Mount Sinai Hospital, and Joseph Globus, MD, described a brain tumor they named “spongioblastoma.”

Leo Loewe, MD, a pioneer in the use of penicillin to cure infectious diseases of the heart, and Israel Strauss, MD, described the first experimental transmission of encephalitis lethargica.

Mount Sinai created its first neuropathology laboratory.

Mount Sinai developed its residency program in neurology.

Morris B. Bender, MD, Professor of Neurology at the Mount Sinai School of Medicine (now the Icahn School of Medicine at Mount Sinai), classified what he called “transient circulatory disturbance of the brain,” which came to be known as transient global ischemia.

The Division of Clinical Neurophysiology is created.

The Department’s Neurochemistry Lab opens.

Mount Sinai creates a clinic for the study and treatment of Parkinson’s disease and other extrapyramidal disorders.

The neurovirology lab is created.

Chairman of the Mount Sinai School of Medicine (now the Icahn School of Medicine at Mount Sinai), Melvin D. Yahr, MD, publishes a study showing L-dopa is an effective treatment for Parkinson’s disease.

Mount Sinai establishes a clinical center for Parkinson’s disease.

Mount Sinai opens the first U.S. clinic for patients with Lou Gehrig’s disease.

NASA invites vestibular researcher Bernard Cohen, MD, to fly monkeys in space on the Russian COSMOS Biosatellite.

The Gustave L. Levy Stroke Unit opens.

C. Warren Olanow, MD, is appointed Chairman and Goldschmidt Professor. Dr. Olanow is a world-renowned expert in Parkinson’s disease whose contributions have included fetal-nigral transplantation, the iron-fusion model of Parkinsonism, and deep brain stimulation.

Mount Sinai opens the Neuroscience and Restorative Care Center for patient care, enabling further integration of rehabilitation, neurosurgery, and neurology disciplines in the care of patients.

The Manhattan HIV Brain Bank is established by Susan Morgello, MD, supported by continuous NIH funding from 1998 to the present.

The Corinne Goldsmith Dickinson Center for Multiple Sclerosis is created. Led by Fred D. Lublin, MD, an international authority on multiple sclerosis, the Center receives a $30 million NIH grant, the largest clinical grant ever given by the NIH.

The Mount Sinai Hospital became a New York State Department of Health-designated stroke center.

The Department creates the multidisciplinary Neuro-Oncology program.

Mount Sinai Stroke Center earned the Joint Commission certification as a Primary Stroke Center, the first and only hospital in Manhattan to do so.

The Friedman Brain Institute is established with Neurology as one of its participating Departments.

Stuart Sealfon, MD, determined that LSD mirrors symptoms and chemical activity of schizophrenia.

The Department of Neurology creates a center for headache and pain medicine.

The Mount Sinai Hospital becomes the first hospital in New York State to receive Joint Commission Comprehensive Stroke Center Certification.

Barbara Vickrey, MD, MPH, is named President of the American Neurological Association.

First neurologist completes the Palliative Medicine Fellowship at Mount Sinai. The Neuro- Palliative Medicine Division is established.

Barbara and Maurice Deane Center for Wellness and Cognitive Health is established.

Several dozen neurology faculty, fellows, and residents served on Medicine COVID Teams during the height of the pandemic surge in New York City.

Faculty members Uraina S. Clark, PhD, and Yasmin Hurd, PhD, publish a seminal article titled, “Toward an Anti-Racist Approach to Biomedical and Neuroscience Research,” in the Journal of Neuroscience with more than 17,000 accesses to date.

Stuart Sealfon, MD, publishes article in the New England Journal of Medicine establishing that occurrences of SARS-CoV-2 asymptomatic transmission in military recruits under strict, supervised quarantine.

The Departments of Neurology and Neurosurgery at The Mount Sinai Hospital achieve the Top 10 rankings by U.S. News and World Report.

Zhenyu Yue, PhD, receives funding from the Parkinson’s Foundation Research Centers to investigate the diversity of dopamine nerve cells in the brain and their vulnerability in Parkinson’s disease.

The David S. and Ruth L. Gottesman Center for Headache Treatment and Translational Research is established.